logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home

US Stock Market Move | Drone concept stock UMAC.US started to rise in early trading, jumping over 11%.

date
22:05 10/03/2026
avatar
GMT Eight
U.S. stocks lift the concept of drone stocks early in the trading session.
On Tuesday, the concept stocks of drones in the US stock market surged in early trading. As of the time of writing, Unusual Machines (UMAC.US) soared more than 11%, SES AI Corp (SES.US) rose more than 9%, Palladyne AI (PDYN.US) rose more than 5.6%, and Draganfly (DPRO.US) rose more than 3%.
Related Articles
China Stock
Power Construction Corporation of China, Ltd (POWERCHINA) has signed a joint venture contract for a 56.36 billion yuan highway design and construction general contracting project.
China Stock
East China Pharmaceuticals (000963.SZ): The clinical trial application for injectable drug HDM2024 has been approved by the US FDA.
HK Stock
SHOUHUI GROUP (02621) expects a net profit of approximately 780 million to 800 million yuan in 2025.
Power Construction Corporation of China, Ltd (POWERCHINA) has signed a joint venture contract for a 56.36 billion yuan highway design and construction general contracting project.
China Stock
East China Pharmaceuticals (000963.SZ): The clinical trial application for injectable drug HDM2024 has been approved by the US FDA.
China Stock
SHOUHUI GROUP (02621) expects a net profit of approximately 780 million to 800 million yuan in 2025.
HK Stock
RECOMMEND
“A+H” Team Continues To Expand Hard Technology Firms Accelerate Global Deployment
“A+H” Team Continues To Expand Hard Technology Firms Accelerate Global Deployment
icon
11/03/2026
Anti‑Stagflation Theme Guides Hong Kong Allocation Institutions Identify Power And Energy Assets As Short‑Term Core
Anti‑Stagflation Theme Guides Hong Kong Allocation Institutions Identify Power And Energy Assets As Short‑Term Core
icon
11/03/2026
U.S. Equities Enter “Always‑On” Trading Era Nasdaq Advances Stock Tokenization Framework
U.S. Equities Enter “Always‑On” Trading Era Nasdaq Advances Stock Tokenization Framework
icon
11/03/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.